|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
29 April 2024 |
|
Main ID: |
NCT01248871 |
|
Date of registration:
|
24/11/2010 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
"Volatile Anesthetic Protection Of Renal Transplants: VAPOR-1-trail
|
|
Scientific title:
|
"Volatile Anesthetic Protection Of Renal Transplants: VAPOR-1-trail |
|
Date of first enrolment:
|
September 2010 |
|
Target sample size:
|
120 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/ct2/show/NCT01248871 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Single (Participant).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Netherlands
| | | | | | | |
|
Contacts
|
|
Name:
|
M.M.R.F Struys, Prof.dr. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University Medical Center Groningen |
|
|
Name:
|
R,J. Ploeg, Prof.dr |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University Medical Center Groningen |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- All patients: Age > 18 years
Exclusion Criteria:
- patient refusal
- BMI< 17, >35
- neurological disorder
- recent use of psycho-active medication, including alcohol.
- Donor-recipient couples from the ABO-incompatible program
- Altruistic donor
Age minimum:
18 Years
Age maximum:
80 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Kidney Donation/Transplantation
|
|
Intervention(s)
|
|
Drug: procedure:sevoflurane-remifentanil/sufentanil
|
|
Drug: volatile agent only during reperfusion
|
|
Drug: propofol-remifentanil/sufentanil
|
|
Primary Outcome(s)
|
|
To compare the renal protective properties of two currently used anaesthetic techniques
[Time Frame: participants will be followed for the duration of hospital stay]
|
|
Secondary ID(s)
|
|
VAPOR 001
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|